Login

WANdisco's partnership with IBM uniquely enables the active replication of data across hybrid, cloud, and on-premises environments.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insights from Neil MacDougall, Managing Partner at Silverfleet Capital | IPEM 2019
00:10:00
Bonterra Resources makes major acquisition that will aid flagship Gladiator Project | Patrick Oliver, CEO, Bonterra Energy CorpBNEFF:PKC
00:10:00
Deciphering the Fixed Income Landscape: Strategies for 2024 and Beyond | Ali Dibadj , CEO , Janus Henderson.
00:10:00
Interview with Darren Collins, CEO of Critical Metals: Advancing U.S. Security of Supply
00:10:00
Trek: Unlocking a Unique Near-Surface Lead-Zinc Opportunity in Gabon
00:10:00
Join us at our stand at the Farnborough Airshow 2022 for an exclusive interview with Bodycote's Keith Murray, VP of Sales and Business Development Europe, to explore Hot Isostatic Pressing and Powdermet® Near Net Shape Technology's benefits for aerospace
00:10:00
Leveraging the Advanced Premium Tax Credit: A Guide for Early Retirees | Dana Anspach, CEO , Sensible Money, LLC.
00:10:00
Evolution of Ariana Minerals: From Nickel to Gold Focus
00:10:00
Unveiling Financial Reporting Challenges with Dan Crowley from AVADA Group | Dan Crowley, CEO , Avada Group Ltd.
00:10:00
CFO Hanna Franzén Discusses Heba Real Estate’s Future | Hanna Franzén, CFO, Heba Real Estate AB.
00:10:00
Inflation Stalemate and Its Impact on Federal Reserve Rate Cuts |Russell Price, Chief Economist , Ameriprise Financial Inc.
00:10:00
Carlsson Noren Macro Fund: Avkastning genom rörelser på räntemarknaden

© 2026 Nehu